Search: Empty
HDSA Names Five HD Human Biology Fellows For 2018
by admin
This week, we announced the winners of the 2018 HD Human Biology Fellowship. These young scientists were chosen for their…
New Study Provides Valuable Insight Into Juvenile Huntington’s Disease
by admin
When symptoms of HD start before the age of 20, this is known as juvenile onset Huntington’s disease, or JHD….
Roche/Genentech Clinical Trial Update Webinar Available to View
by admin
If you missed the clinical trials update webinar presented by Roche on Wednesday the 26th, it’s now available for viewing…
Roche Provides Info About Ongoing HD Program & Announces Two Upcoming Trials; HDSA to Host Webinar
by admin
This past Sunday at the plenary meeting of the European Huntington’s Disease Network (EHDN), Roche Pharmaceuticals announced some details about…
HD Featured in Science Magazine
by admin
The prestigious Science magazine published an article on Huntington’s disease this week, describing the huntingtin-lowering ASO drug developed by Ionis,…
Voice Your Opinions About The Future Of CRISPR
by admin
Community research surveys are valuable ways for researchers to get input from HD patients, families and caregivers about a variety…
DNA Repair Research Uncovers New Drug Targets
by admin
Researchers led by Ray Truant at McMaster University in Canada are investigating how DNA repair could help correct some of…
Positive Trends in Data from Ionis Huntingtin-Lowering Trial
by admin
On April 24th, 2018, Ionis Pharmaceuticals made an announcement about the Phase 1/2 clinical trial of their huntingtin-lowering drug, IONIS-HTTRx…
Appreciating Research Volunteers
by admin
This week HDSA is celebrating National Volunteer Appreciation Week. This goes for research, too! We’d like to express our heartfelt…
Interpreting this Week’s News: Data from the First Phase of the Ionis-Roche Trial
by admin
This week, Ionis Pharmaceuticals shared data from the successful safety trial for their huntingtin-lowering drug. The data confirms what was…
CHDI’s Huntington’s Disease Conference in Palm Springs
by admin
This week in Palm Springs, California marks the 13th Annual HD Therapeutics Conference. This yearly conference draws academic and industry…
This Week In Huntington’s Disease Research
by admin
March 8th, 2018 Interpreting this week’s news: data from the first phase of the Ionis-Roche Trial This week, Ionis Pharmaceuticals…
First HD-COPE Meeting
by admin
The first meeting of the Huntington’s Disease Coalition for Patient Engagement (HD-COPE) took place in London this week. HD-COPE unites…
FAQs: Ionis Huntingtin-Lowering Trial
by admin
Below are some frequently asked questions about IONIS-HTTRx, which recently completed a successful clinical trial for safety. Click here for…
Lighting the way: A new biomarker for Huntington’s disease
by admin
A new biomarker reveals brain changes in early Huntington’s disease. By Melissa Christianson on April 20, 2015Edited by Dr Jeff…
